Dr. Michele Matarazzo interviews Prof. Marjan Jahanshahi on the long term results of the clinical trial of deep brain stimulation of the nucleus basalis of Meynert in people with Parkinson’s disease dementia. In the discussion Prof. Jahanshahi shares thoughts on the future directions of the field. Read the article.
Read MoreIn this episode, Dr. Hugo Morales Briceño discusses the spectrum of phenotypes and genotypes of children with hyperkinetic movement disorders with Dr. Belén Pérez Dueñas and Prof. Manju Kurian. Read the article.
Read MoreDr. Sarah Lidstone interviews Dr. Chang-Qing Gao & Prof. Ji-fung Guo about their recent research on the sensitivity of sniffer dogs for diagnosing Parkinson’s disease. Read the article.
Read MoreMembers of the task force for Axial Postural Abnormalities in Parkinsonism, Prof. Tinazzi, Dr. Geroin and Dr. Artusi, discuss new nosology and cut-off values. Read the article.
Read MoreDr. Sara Schaefer discusses with Prof. Richard Smeyne how viruses including COVID-19 increase the susceptibility to oxidative stress-induced parkinsonism in mouse models, the historical evidence to support a virus-parkinsonism link, the biological basis for this correlation, and ways it may be prevented. Journal CME is available until July 29, 2023 Read the article.
Read MoreShifts in the Society and the landscape of the field are set to guide growth in medical education. Dr. Veronica Santini shares insights about this new direction with Dr. Sara Schaefer and our listeners.
Read MoreFollowing a year of impactful neuroimaging papers, Prof. Oury Monchi discusses with Dr. Michele Matarazzo the most promising advances involving machine learning, tracers, and precision in determining imaging processes.
Read MoreWearable sensors, electronic rating scales, eDiaries — Dr. Álvaro Sánchez-Ferro discusses with Dr. Michele Matarazzo how these and a broad range of other emerging digital technologies can help take movement disorder evaluation outside the clinic and into patients’ everyday environment.
Read MoreDr. Ron Postuma outlines with Dr. Eduardo de Pablo-Fernández several advances this year he thinks will «revolutionize» Parkinson’s disease care, and shifts the field may need to make as a whole to help us reach the next phase of prodromal and personalized treatments.
Read More